Pdt Partners, LLC Myriad Genetics Inc Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $298,586 - $383,493	-11,760 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $1.05 Million - $1.67 Million	-52,714 Reduced 81.76%	11,760 $358,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $741,456 - $1.21 Million	-60,975 Reduced 48.61%	64,474 $1.28 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $1.41 Million - $1.85 Million	125,449 New	125,449 $1.64 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.